PEG-interleukin-2 April 12, 2017 PEG-interleukin-2 Trade Name Orphan Indication Primary immunodeficiencies associated with T-cell defects USA Market Approval USA USA Designation Date 1990-02-01 00:00:00 Sponsor Chiron Corporation;4560 Horton Street;Emeryville, California, 94608
